High affinity, anti-human IgE antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 10, 2013
Grant Date -
Feb 28, 2013
app pub date -
Jul 27, 2012
filing date -
Feb 1, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to high affinity human monoclonal antibodies, particularly those directed against isotypic determinants of immunoglobulin E (IgE), as well as direct equivalents and derivatives of these antibodies. These antibodies bind to their respective target with an affinity at least 100 fold greater than the original parent antibody. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully